case_images: PMC11141706_01
case_images: Various stages of treatment for the Case. (A) Baseline; (B) After two months of treatment with 2% Crisaborole Ointment; (C) After undergoing one session of Q-switched 532nm Nd:YAG laser treatment.
case_images: JIR-17-3419-g0001.jpg
case_images: PMC11141706_01_JIR-17-3419-g0001.jpg
case_images: f0001
case_images: The affected area exhibited peeling skin and a small amount of yellow purulent discharge, limited to the tattooed region (Figure 1A). The treatment progress is depicted in (Figure 1A-C and 2A-D).
case_images: Various stages of treatment for the Case. (A) Baseline; (B) After one month of treatment with 2% Crisaborole Ointment; (C) After two months of treatment with 2% Crisaborole Ointment; (D) After undergoing one session of Q-switched 532nm Nd:YAG laser treatment.
case_images: JIR-17-3419-g0002.jpg
case_images: PMC11141706_01_JIR-17-3419-g0002.jpg
case_images: f0002
case_images: Dermoscopy showed irregularly distributed white structures, distinct prominent branching vessels, white scales, yellow crusts, exudate, and, in some areas, gray-brown dot-like pigment deposition (Figure 2A). Dermoscopic examination revealed multiple red proliferative lesions with clearer boundaries, the presence of exogenous pigments, dot-like vessels, white reticular structures, and brown pigment deposits (Figure 2C). Residual pigmentation was visibly eradicated, the raised scar tissue on the lips exhibited a tendency to flatten, and dermoscopy revealed multiple red proliferative lesions with clearer boundaries, presence of exogenous pigments, dot-like and linear vessels, scabs, white reticular structures, and brown pigment deposition (Figure 2D). The treatment progress is depicted in (Figure 1A-C and 2A-D).